Company News
Our new partnership with Kytopen, and the future of lab instrument data
Check out our full press release here for more details. Earlier this week, we announced a new instrument collaboration with Kytopen, a leader in the development and commercialization of non-viral transfection tools for genome engineering. This partnership brings the power of Ganymede’s Lab-as-Code…
![](https://blog.ganymede.bio/content/images/2023/09/Blue-Modern-Company-Our-Products-Instagram-Post--1280---720-px-.png)
Accelerate your analysis with Ganymede’s new data products.
Data is at the heart of every life sciences company. And yet, all too often, it’s treated more as a by-product than an asset. Data management across the industry typically means putting your data anywhere that’s convenient and compliant, without much concern for accessibility and reusability. Meanwh…
![](https://blog.ganymede.bio/content/images/2023/05/Webinar--2--1280---720-px---4-.png)
Bloomberg TV’s New to The Street Welcomes Our CEO and Co-Founder Nathan Clark
Did you know that today, scientists spend upwards of 20-30% of their work time on data management? Host of Bloomberg TV’s New to The Street Jane King recently sat down with our CEO and co-founder Nathan Clark to discuss how Ganymede solves that problem, accelerating research and providing greater d…
![](https://blog.ganymede.bio/content/images/2023/04/Bloomberg_TV-s_New_to_The_Street_Welcomes_Our_CEO_and_Co-Founder_Nathan_Clark_frame-2.png)
Modern data clouds are vital for biotechs. Unlock their power and don’t get left behind.
Join us on February 23rd 12PM EST for our 1st live webinar. Register here. Cutting-edge mRNA vaccines, advanced cell & gene therapies, and even bringing back extinct animal species: the pace of innovation is accelerating everywhere and every day in the life sciences. Yet, like virtually all other…
![](https://blog.ganymede.bio/content/images/2023/02/Meet-Nathan--3-.png)